{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:46:25Z","timestamp":1785681985332,"version":"3.56.0"},"reference-count":17,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014The immunohistochemical detection of CD34 protein using QBEND10 antibody in bone marrow trephine biopsies was shown recently to be a precise method for quantitation of blasts and a possibly useful approach in diagnosis and classification of myelodysplastic syndrome.<\/jats:p>\n                  <jats:p>Objectives.\u2014To evaluate CD34+ cells in bone marrow biopsies with various diagnoses and to assess how counts obtained using this method correlate with blast counts obtained by traditional morphologic evaluation of bone marrow smears.<\/jats:p>\n                  <jats:p>Design.\u2014Bone marrow trephine biopsies from 108 adult patients were evaluated by immunohistochemistry using anti-CD34 antibody (QBEND10). CD34+ mononuclear cells were counted and compared with the blast counts in the bone marrow aspirate smears or imprints. CD34+ mononuclear cell clusters and CD34+ megakaryocytes were also recorded. The type of positivity (membranous vs cytoplasmic) and the percentage of CD34+ megakaryocytes were evaluated because the presence of CD34+ megakaryocytes was recently suggested to be present in myelodysplastic syndrome, but not in myeloproliferative disease or nonneoplastic bone marrow.<\/jats:p>\n                  <jats:p>Results.\u2014Six of 24 biopsies with partial involvement by non-Hodgkin lymphoma and 5 of 60 biopsies with reactive changes had 5% to 10% CD34+ mononuclear cells and were associated with lymphocytosis and increased hematogones. The CD34+ mononuclear cell clusters were found only in myelodysplastic syndrome and myeloproliferative disease. The CD34+ megakaryocytes were present in all diagnostic groups.<\/jats:p>\n                  <jats:p>Conclusion.\u2014The number of CD34+ mononuclear cells was often slightly higher than the number of myeloid blasts in the bone marrow smears, probably due to increased hematogones. The presence and the number of CD34+ megakaryocytes do not appear to have diagnostic value, but this finding should be further investigated in relation to clinical parameters.<\/jats:p>","DOI":"10.5858\/2002-126-0823-cqiitb","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:05:31Z","timestamp":1611893131000},"page":"823-828","source":"Crossref","is-referenced-by-count":18,"title":["CD34\/QBEND10 Immunostaining in the Bone Marrow Trephine Biopsy"],"prefix":"10.5858","volume":"126","author":[{"given":"Goran","family":"Torlakovic","sequence":"first","affiliation":[{"name":"From the Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Langholm","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Torlakovic","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"2021012909051243800_i1543-2165-126-7-823-b1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias (FAB) co-operative group.","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes.","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","article-title":"CD34: structure, biology, and clinical utility.","volume":"87","author":"Krause","year":"1996","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.7692600","article-title":"Binding of L-selectin to the vascular sialomucin CD34.","volume":"262","author":"Baumheter","year":"1993","journal-title":"Science"},{"key":"2021012909051243800_i1543-2165-126-7-823-b5","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood.V85.11.3040.bloodjournal85113040","article-title":"Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells.","volume":"85","author":"Fackler","year":"1995","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V75.12.2417.2417","article-title":"Expression of the CD34 gene in vascular endothelial cells.","volume":"75","author":"Fina","year":"1990","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jcp.48.4.291","article-title":"QBEND10 for the diagnosis of myelodysplastic syndrome in routinely processed bone marrow biopsy specimens.","volume":"48","author":"Horny","year":"1995","journal-title":"J Clin Pathol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jcp.52.9.688","article-title":"Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.","volume":"52","author":"Toth","year":"1999","journal-title":"J Clin Pathol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0609.2000.90047.x","article-title":"CD34\/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.","volume":"64","author":"Baur","year":"2000","journal-title":"Eur J Haematol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ajcp\/110.3.313","article-title":"The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy.","volume":"110","author":"Rimsza","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b12","first-page":"218","article-title":"Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.","volume":"12","author":"Willman","year":"1999","journal-title":"Mod Pathol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V73.2.543.543","article-title":"Hematogones: a multiparameter analysis of bone marrow precursor cells.","volume":"73","author":"Longacre","year":"1989","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002770050149","article-title":"Immunotyping of blasts in human bone marrow.","volume":"72","author":"Oertel","year":"1996","journal-title":"Ann Hematol"},{"key":"2021012909051243800_i1543-2165-126-7-823-b15","doi-asserted-by":"crossref","first-page":"17540","DOI":"10.1016\/S0021-9258(19)37076-0","article-title":"Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34.","volume":"267","author":"Fackler","year":"1992","journal-title":"J Biol Chem"},{"key":"2021012909051243800_i1543-2165-126-7-823-b16","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V80.12.3022.3022","article-title":"Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation.","volume":"80","author":"Debili","year":"1992","journal-title":"Blood"},{"key":"2021012909051243800_i1543-2165-126-7-823-b17","first-page":"171","article-title":"CD34 expression in megakaryocytes favors myelodysplasia [abstract].","volume":"14","author":"Machhi","year":"2001","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/7\/823\/2729155\/0003-9985(2002)126_0823_cqiitb_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/7\/823\/2729155\/0003-9985(2002)126_0823_cqiitb_2_0_co_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:24Z","timestamp":1764790464000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/7\/article-p823.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2002-126-0823-cqiitb","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}